as on September 13, 2025 at 1:29 am IST
52 Week's Low
52 Week's High
8.85%
Downside
950.00%
Upside
Check Renovaro Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$45.9M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
159513000.00%
Compare market cap, revenue, PE, and other key metrics of Renovaro Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $45.9M | NA | NA | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Renovaro Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Renovaro Inc investment value today
Current value as on today
₹35,442
Returns
Returns from Renovaro Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Search interest for Renovaro Inc Stock has increased by 183% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:183% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 145.3%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 213.8%
Price Dip
In the last 1 month, RENB stock has moved down by -16.9%
Organisation | Renovaro Inc |
Headquarters | 2080 Century Park East, Los Angeles, CA, United States, 90067 |
CEO | Mr. David H. Weinstein |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. David H. Weinstein | CEO & Director |
Mr. Nathen Fuentes CPA | Chief Financial Officer |
Mr. Greg Duczynski Ph.D. | Senior Vice President for Clinical Operations |
Renovaro Inc share price today is $0.2 as on at the close of the market. Renovaro Inc share today touched a day high of $0.2 and a low of $0.2.
Renovaro Inc share touched a 52 week high of $2.1 on and a 52 week low of $0.18 on . Renovaro Inc stock price today i.e. is closed at $0.2,which is 90.48% down from its 52 week high and 9.71% up from its 52 week low.
Renovaro Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Renovaro Inc (RENB) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Renovaro Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Renovaro Inc share’s latest price of $0.2 as on September 13, 2025 at 1:29 am IST, you will get 50.0000 shares of Renovaro Inc. Learn more about
fractional shares .